The Rapid Coronavirus Antibody Test: Can We Improve Accuracy?
Ina P Pavlova, Sujit S Nair, Natasha Kyprianou, Ash K Tewari, Ina P Pavlova, Sujit S Nair, Natasha Kyprianou, Ash K Tewari
No abstract availableKeywords: SARS-CoV-2 antibodies; lateral flow assays; neutralizing antibodies; paper based analytical devices; rapid tests.
Figures
References
- Amanat F, Stadlbauer D, Strohmeier S, Nguyen THO, Chromikova V, McMahon M, et al. . A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. (2020) 26, 1033–36. 10.1038/s41591-020-0913-5
- Bendavid E, Mulaney B, Sood N, Shah S, Ling E, Bromley-Dulfano R, et al. COVID-19 Antibody seroprevalence in Santa Clara County, California. medRxiv. (2020). 10.1101/2020.04.14.20062463
- Whitman JD, Hiatt J, Mowery CT, Shy BR, Yu R, Yamamoto TN, et al. . Test performance evaluation of SARS-CoV-2 serological assays. medRxiv. (2020). 10.1101/2020.04.25.20074856
- Tang YW, Schmitz JE, Persing DH, Stratton CW. The laboratory diagnosis of COVID-19 infection: current issues and challenges. J Clin Microbiol. (2020) 58:e00512–20. 10.1128/JCM.00512-20
- Petherick A. Developing antibody tests for SARS-CoV-2. Lancet. (2020) 395:1101–2. 10.1016/S0140-6736(20)30788-1
- Tan W, Lu Y, Zhang J, Wang J, Dan Y, Tan Z, et al. . Viral kinetics and antibody responses in patients with COVID-19. medRxiv. (2020). 10.1101/2020.03.24.20042382
- Jiang H, Li Y, Zhang H, Wang W, Men D, Yang X, et al. . Global profiling of SARS- CoV-2 specific IgG/IgM responses of convalescents using a proteome microarray. medRxiv. (2020). 10.1101/2020.03.20.20039495
- Wajnberg A, Mansour M, Leven E, Bouvier NM, Patel G, Firpo A, et al. Humoral immune response and prolonged PCR positivity in a cohort of 1343 SARS-CoV 2 patients in the New York City region. medRxiv. (2020). 10.1101/2020.04.30.20085613
- Koopmans M, Haagmans B. Assessing the extent of SARS-CoV-2 circulation through serological studies. Nat Med. (2020) 26:1171–72. 10.1038/s41591-020-1018-x
- Long Q, Tang X, Shi Q, Li Q, Deng H, Yuan J, et al. . Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med. (2020) 26, 1200–04. 10.1038/s41591-020-0965-6
- Wu F, Wang A, Liu M, Wang Q, Chen J, Xia S, et al. Neutralizing antibody responses to SARS- CoV-2 in a COVID-19 recovered patient cohort and their implications. medRxiv. (2020). 10.1101/2020.03.30.20047365
- Iwasaki A, Yang Y. The potential danger of suboptimal antibody responses in COVID-19. Nat Rev Immunol. (2020) 20, 339–41. 10.1038/s41577-020-0321-6
- Tan CW, Chia WN, Qin X, Liu P, Chen MI, Tiu C, et al. . A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction. Nat Biotechnol. (2020). 10.1038/s41587-020-0631-z. [Epub ahead of print].
- Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. (2020) 579:270–3. 10.1038/s41586-020-2012-7
- Fridley GE, Le H, Yager P. Highly sensitive immunoassay based on controlled rehydration of patterned reagents in a 2-dimensional paper network. Anal Chem. (2014) 86:6447–53. 10.1021/ac500872j
- Fu E, Liang T, Spicar-Mihalic P, Houghtaling J, Ramachandran S, Yager P. Two-dimensional paper network format that enables simple multistep assays for use in low-resource settings in the context of malaria antigen detection. Anal Chem. (2012) 84:4574–9. 10.1021/ac300689s
- Grant BD, Smith CA, Castle PE, Scheurer ME, Richards-Kortum R. A paper-based immunoassay to determine HPV vaccination status at the point-of-care. Vaccine. (2016) 34:5656–63. 10.1016/j.vaccine.2016.09.021
Source: PubMed